Forvis Mazars Wealth Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Forvis Mazars Wealth Advisors's DGX Position: Q2 2023 in Review
Forvis Mazars Wealth Advisors sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 1,934 shares — an estimated $274K sold.
Forvis Mazars Wealth Advisors first reported a position in DGX in Q2 2018 and held it in 20 quarters. The position peaked at $383K in Q4 2020. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.
- Forvis Mazars Wealth Advisors reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
- Forvis Mazars Wealth Advisors sold 1,934 Quest Diagnostics shares in Q2 2023, an estimated $274K.
- Forvis Mazars Wealth Advisors first reported a position in Quest Diagnostics in Q2 2018 and held it in 20 quarters.
- Forvis Mazars Wealth Advisors's Quest Diagnostics position peaked at $383K in Q4 2020.
- 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.
Based on Forvis Mazars Wealth Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.